Advertisement

Clinical Applications of PET/MRI in Brain Imaging

  • Francesco Fraioli
  • Karar Obeed AlmansoryEmail author
Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

Brain imaging is one of the valuable applications of the hybrid PET/MRI given the anatomical and physiological complexity of the brain and the subtlety of the neurological changes that accompany many of the neurodegenerative, epileptic, and oncological diseases. The limited resolution of CT in imaging brain makes the MRI the ideal modality for neuroimaging. This resulted in growing interest in the medical, physics, and pharmaceutical communities to develop novel radiopharmaceuticals and apply new MRI sequences for early diagnosis, predicting the behavior and having a better insight of the neurological disorders. This chapter provides a concise overview of the combined PET/MRI clinical uses in neuroimaging of patients with neurodegenerative, epileptic and brain neoplastic diseases. It also compares its advantages and disadvantages to those of other available imaging modalities.

References

  1. 1.
    Fraioli F, Punwani S. Clinical and research applications of simultaneous positron emission tomography and MRI. Br J Radiol. 2014;87(1033):20130464.PubMedGoogle Scholar
  2. 2.
    Kalemis A, Delattre BMA, Heinzer S. Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer’s perspective. Magn Reson Mater Phys Biol Med. 2013;26(1):5–23.Google Scholar
  3. 3.
    Tudisca C, Nasoodi A, Fraioli F. PET-MRI. Nucl Med Commun. 2015;36(7):666–78.PubMedGoogle Scholar
  4. 4.
    Schwenzer NF, et al. Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients—current state of image quality. Eur J Radiol. 2012;81(11):3472–8.PubMedGoogle Scholar
  5. 5.
    Hirata Y, et al. Voxel-based morphometry to discriminate early Alzheimer’s disease from controls. Neurosci Lett. 2005;382(3):269–74.PubMedGoogle Scholar
  6. 6.
    Guo X, et al. Voxel-based assessment of gray and white matter volumes in Alzheimer’s disease. Neurosci Lett. 2010;468(2):146–50.PubMedGoogle Scholar
  7. 7.
    Goubran M, et al. Assessment of PET & ASL metabolism in the hippocampal subfields of MCI and AD using simultaneous PET-MR. EJNMMI Phys. 2015;2(Suppl 1):A73.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. DTI analyses and clinical applications in Alzheimer’s disease. J Alzheimers Dis. 2011;26(Suppl 3):287–96.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Prasad G, Nir TM, Toga AW, Thompson PM. Tractography density and network measures in Alzheimer’s disease. In: 2013 IEEE 10th International Symposium on Biomedical Imaging, vol. 2013; 2013. p. 692–5.Google Scholar
  10. 10.
    Heiss W-D, Raab P, Lanfermann H. Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med. 2011;52(10):1585–600.PubMedGoogle Scholar
  11. 11.
    Rees JH. Diagnosis and treatment in neuro-oncology: an oncological perspective. Br J Radiol. 2011;84(Spec Iss 2):S82–9.PubMedGoogle Scholar
  12. 12.
    Knopp EA, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology. 1999;211(3):791–8.PubMedGoogle Scholar
  13. 13.
    Scott JN, Brasher PMA, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology. 2002;59(6):947–9.PubMedGoogle Scholar
  14. 14.
    Bisdas S, et al. Metabolic mapping of gliomas using hybrid MR-PET imaging. Investig Radiol. 2013;48(5):295–301.Google Scholar
  15. 15.
    Bisdas S, lá Fougere C, Ernemann U. Hybrid MR-PET in neuroimaging. Clin Neuroradiol. 2015;25:275–81.PubMedGoogle Scholar
  16. 16.
    Halac G, et al. Compatibility of MRI and FDG-PET findings with histopathological results in patients with focal cortical dysplasia. Seizure. 2017;45:80–6.PubMedGoogle Scholar
  17. 17.
    Shin HW, et al. Initial experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy. Seizure. 2015;31:1–4.PubMedGoogle Scholar
  18. 18.
    Ward BP. Arab Health: is PET/MRI really worth the extra cost? AuntMinnie Europe; 2013. p. 28–29.Google Scholar
  19. 19.
    Bailey DL, et al. Combined PET/MR: the real work has just started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany. Mol Imaging Biol. 2015;17(3):297–312.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Institute of Nuclear MedicineUniversity College LondonLondonUK

Personalised recommendations